Samsara Therapeutics
Alkmini is a major expert in target identification using CRISPR/Cas9 screening and was most recently at the Frankfurt CRISPR Screening Centre at Goethe University in Frankfurt, and previously at the IGBMC in Strasbourg. She holds a PhD in Biochemistry from the University of Thessaly in Greece where she also completed her graduate studies.
Samsara Therapeutics
Samsara Therapeutics, Inc. is a biopharmaceutical company aiming to discover the first-in-class therapeutics that treat rare genetic and neurodegenerative diseases and extend a healthy lifespan. Samsara's platform is the largest ever pipeline for the identification, chemical optimization, and in vivo validation of compounds that enhance autophagy.